Oncology Drugs Market Research Report, Growth & Forecast

According to our (Global Info Research) latest study, the global Letrozole Tablets market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR...

According to our (Global Info Research) latest study, the global Radionuclide-conjugated Drugs market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032...

According to our (Global Info Research) latest study, the global Therapeutic Radioligands Drug market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032...

According to our (Global Info Research) latest study, the global Venetoclax market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %du...

The Multiple Myeloma Market was valued at US$ 22.3 billion in 2024 and is anticipated to reach US$ 34.58 billion by 2032, at a CAGR of 0.056 from 2026 to 2032. The report delivers in-depth insights in...

The Uveal melanoma Treatment Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regi...

The global glioblastoma multiforme treatment market size was estimated at USD 4.04 billion in 2025 and is projected to reach USD 7.87 billion by 2033, growing at a CAGR of 8.69% from 2026 to 2033. The...

HNY Research projects that the Hematologic Malignancies Treatment market size will grow from 71932.2 Million USD in 2025 to 302030.04 Million USD by 2031, at an estimated CAGR of 27.01%. The base year...

HNY Research projects that the Vinca Alkaloid market size will grow from 122.4 Million USD in 2025 to 206.04 Million USD by 2031, at an estimated CAGR of 9.07%. The base year considered for the study...

The Outpatient Oncology Infusion Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including...

The Targeted Therapy Market was valued at US$ 79.18 billion in 2024 and is anticipated to reach US$ 147.16 billion by 2033, at a CAGR of 0.072 from 2026 to 2032. The report delivers in-depth insights...

The global immunotherapy drugs market size was estimated at USD 285.73 billion in 2025 and is expected to reach USD 675.98 billion by 2033, growing at a CAGR of 11.41% from 2026 to 2033. This market i...

The Gynecological Cancers Therapeutics Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, incl...

The Mycosis Fungoides Treatment Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including r...

The Refractory Multiple Myeloma Market was valued at USD 2.4 billion in 2022 and is anticipated to reach by , at a CAGR of 0.047 from 2026 to 2032. The report delivers in-depth insights into key marke...

HNY Research projects that the Bruton's Tyrosine Kinase (BTK) Inhibitors market size will grow from 7722.62 Million USD in 2025 to 10485.27 Million USD by 2031, at an estimated CAGR of 5.23%. The base...

HNY Research projects that the Epirubicin Hydrochloride market size will grow from 244.56 Million USD in 2025 to 297.16 Million USD by 2031, at an estimated CAGR of 3.3%. The base year considered for...

HNY Research projects that the Follicular Lymphoma Drugs market size will grow from 2007.5 Million USD in 2025 to 3291.54 Million USD by 2031, at an estimated CAGR of 8.59%. The base year considered f...

The PARP Inhibitors Market was valued at US$ 3.53 billion in 2023 and is anticipated to reach US$ 6.64 billion by 2031, at a CAGR of 0.083 from 2026 to 2032. The report delivers in-depth insights into...

This report presents a detailed and holistic analysis of the global Gynecological Cancers Drug market. It integrates quantitative data with qualitative insights to equip readers with the necessary inf...

This report presents a detailed and holistic analysis of the global CAR T-Cell Therapy market. It integrates quantitative data with qualitative insights to equip readers with the necessary information...

This report presents a detailed and holistic analysis of the global Immune Checkpoint Blockers market. It integrates quantitative data with qualitative insights to equip readers with the necessary inf...

The Cancer Therapeutics Market was valued at US$ 168.15 billion in 2024 and is anticipated to reach US$ 491.60 billion by 2032, at a CAGR of 0.126 from 2026 to 2032. The report delivers in-depth insig...

This study covers the world outlook for liver cancer drugs across more than 190 ... not discuss the specific players in the market serving the latent demand, nor specific details ... the P.I.E., for liver cancer drugs. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...

This econometric study covers the world outlook for multiple myeloma therapeutics across more than 200 countries. For each year reported, ... worldwide latent demand, or the P.I.E., for multiple myeloma therapeutics. It also shows how the P.I.E. is divided across the world’s regional and national markets. For each ...

This econometric study covers the world outlook for non-small cell lung cancer therapeutics across more than 200 countries. For each year reported, ... worldwide latent demand, or the P.I.E., for non-small cell lung cancer therapeutics. It also shows how the P.I.E. is divided across the world’s regional and national markets. For each ...

This study covers the world outlook for pancreatic cancer drugs across more than ... not discuss the specific players in the market serving the latent demand, nor specific ... the P.I.E., for pancreatic cancer drugs. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...

... study covers the world outlook for prostate cancer therapeutics across more than ... not discuss the specific players in the market serving the latent demand, nor specific ... P.I.E., for prostate cancer therapeutics. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...

... display the global Intravesical Bacillus Calmette market. Chapter 1, to describe Intravesical Bacillus Calmette Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Intravesical Bacillus Calmette, with ...

This study covers the world outlook for angiogenesis inhibitors and stimulators across more than 190 countries. For each year ... demand, or the P.I.E., for angiogenesis inhibitors and stimulators. It also shows how the P.I.E. is divided across the world's regional and national markets. For each country, I ...

This study covers the world outlook for breast cancer monoclonal antibodies (mAb) across more than 190 countries. For each year ... demand, or the P.I.E., for breast cancer monoclonal antibodies (mAb). It also shows how the P.I.E. is divided across the world's regional and national markets. For each country, I ...

This study covers the world outlook for cancer immunotherapies across more than ... not discuss the specific players in the market serving the latent demand, nor specific ... the P.I.E., for cancer immunotherapies. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...

This study covers the world outlook for cancer-treating drugs across more than ... not discuss the specific players in the market serving the latent demand, nor specific ... the P.I.E., for cancer-treating drugs. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...

This study covers the world outlook for checkpoint inhibitors across more than ... not discuss the specific players in the market serving the latent demand, nor specific ... the P.I.E., for checkpoint inhibitors. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...

This study covers the world outlook for colorectal cancer drugs across more than ... not discuss the specific players in the market serving the latent demand, nor specific ... the P.I.E., for colorectal cancer drugs. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...

... study covers the world outlook for colorectal cancer treatments across more than ... not discuss the specific players in the market serving the latent demand, nor specific ... P.I.E., for colorectal cancer treatments. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...

This study covers the world outlook for gastric cancer drugs across more than ... not discuss the specific players in the market serving the latent demand, nor specific details ... the P.I.E., for gastric cancer drugs. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...

This study covers the world outlook for hematological cancer treatments across more than 190 countries. For each year reported, ... latent demand, or the P.I.E., for hematological cancer treatments. It also shows how the P.I.E. is divided across the world's regional and national markets. For each country, I also ...

This study covers the world outlook for immunotherapy drugs across more than 190 ... not discuss the specific players in the market serving the latent demand, nor specific details ... the P.I.E., for immunotherapy drugs. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...

... study covers the world outlook for liver cancer therapeutics across more than ... not discuss the specific players in the market serving the latent demand, nor specific ... the P.I.E., for liver cancer therapeutics. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...

This study covers the world outlook for non-hematological cancer treatments across more than 190 countries. For each year reported, ... demand, or the P.I.E., for non-hematological cancer treatments. It also shows how the P.I.E. is divided across the world's regional and national markets. For each country, I also ...

This study covers the world outlook for ovarian cancer drugs across more than ... not discuss the specific players in the market serving the latent demand, nor specific details ... the P.I.E., for ovarian cancer drugs. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...

This study covers the world outlook for ovarian cancer drugs and diagnostics across more than 190 countries. For each year reported, ... demand, or the P.I.E., for ovarian cancer drugs and diagnostics. It also shows how the P.I.E. is divided across the world's regional and national markets. For each country, I ...

... study covers the world outlook for prostate cancer treatments across more than ... not discuss the specific players in the market serving the latent demand, nor specific ... the P.I.E., for prostate cancer treatments. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...

... from 90 million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Paclitaxel in global market, especially in North America, Europe ... growth rate by type, application, from 2014 to 2019. Chapter 12, Paclitaxel market forecast, by regions, type and application, with ...

... display the global Chemotherapy Infusion Pumps market. Chapter 1, to describe Chemotherapy Infusion Pumps Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Chemotherapy Infusion Pumps, with ...

... 2017; Chapter 4, to show the global market by regions, with sales, revenue and market share of Medical Asparaginase, for each region, from 2013 to 2018; Chapter 5, 6, 7, 8 and 9, to analyze ...

... xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Topotecan Hydrochloride in global market, especially in North America, Europe ...

... the Report: This report focuses on the Checkpoint Inhibitors for Treating Cancer in global market, especially in North America, Europe ... to deeply display the global Checkpoint Inhibitors for Treating Cancer market. Chapter 1, to describe Checkpoint Inhibitors for Treating Cancer Introduction, product scope ...

... manufacturers of Peptide Cancer Vaccine, with price, sales, revenue and global market share of Peptide Cancer Vaccine in 2017 and 2018. Chapter 3, the Peptide Cancer Vaccine competitive situation, sales, revenue and global market share ...